Baltimore startup Delfi Diagnostics raises $225M with plans to change how lung cancer is diagnosed
July 18, 2022 at 16:50 PM EDT
Delfi Diagnostics' blood test for lung cancer is backed by some of the biggest names in Baltimore, such as T. Rowe Price Associates and Brown Advisory.
